Skip to main content
. 2016 Jan 25;34(11):1248–1255. doi: 10.1200/JCO.2015.63.6738

Table 2.

Patient Characteristics (N = 235)

Characteristic No. (%) Median Range Interquartile Range
Sex
 Male 119 (50.6)
 Female 116 (49.4)
Race
 White 194 (82.6)
 Nonwhite 41 (17.4)
Age at RT initiation (years) 7.2 1.0-24.4 3.9-12.3
 < 3 43 (18.3)
 ≥ 3 192 (81.7)
Age at latest audiogram (years) 17.0 2.1-36.3 12.6-21.1
Time from RT initiation to latest audiogram (years) 9.0 0.8-16.0 6.0-11.1
Post-RT audiograms, No. 11 1-19 7-14
Shunt status
 Yes 76 (32.3)
 No 159 (67.7)
Surgeries, No.
 ≤ 1 157 (66.8)
 > 1 78 (33.2)
CRD (Gy)
 Left ear 29.5 0.0-61.7 17.0-44.7
 Right ear 28.8 0.0-63.9 15.8-42.9
Tumor location
 Infratentorial 86 (36.6)
 Supratentorial 149 (63.4)
Histologic diagnosis
 Ependymoma 92 (39.1)
 Craniopharyngioma 73 (31.1)
 Juvenile pilocytic astrocytoma 37 (15.7)
 Anaplastic astrocytoma 7 (3.0)
 Optic pathway glioma 5 (2.1)
 Low-grade astrocytoma 3 (1.3)
 Ganglioglioma 3 (1.3)
 Oligodendroglioma 3 (1.3)
 Glioblastoma multiforme 2 (0.9)
 Other astroglial tumors* 10 (4.1)

Abbreviations: CRD, cochlear radiation dose; RT, radiation therapy.

*

World Health Organization I & II, central neurocytoma, choroid plexus carcinoma, malignant glial neuronal, malignant neurocytoma, neurocytoma, pilomyxoid astrocytoma, and pleomorphic xanthroastrocytoma.